The present study shows, for the first time, that the inflammatory IL-1β is an inducer of chemoresistance to cisplatin through activation of the IL-1β/IL-1RI/β-catenin signaling pathway that we described previously as operating in the induction of expression of genes associated with cell survival and resistance to anti-cancer drugs [5,6]. This evidence concerns the gene IL1B and cancer.